Staff Physician Cleveland Clinic Taussig Cancer Institute
Oncology
Dr. Alberto J. Montero, MD
|
|
Give Review
Doctor Alberto J. Montero, MD practices Oncology. He received 9 awards: "Six Sigma Green Belt", "CMS Meaningful Use Stage 1 Certification", "Six Sigma Champion", "Papanicolaou Corps for Cancer Research Pap Corps Fellow", "Methods in Cancer Research Workshop Travel Award", "Travel Award", "Division of Pathology Tropical Medicine Research Award", "McLaughlin Medical Student Fellow" and "Dean's List". Alberto Montero is a published doctor. He published 62 publications, including: 'The department without walls. Acceptability, cost, and utilization of interactive video technology.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Clinical outcomes in breast Cancer patients with HIV/AIDS: a retrospective study.
- Erratum to: Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast Cancer.
- Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast Cancer.
- Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or un...
- Phase II Study of Neoadjuvant Therapy with Docetaxel, Cisplatin, Panitumumab Plus Radiation Therapy Followed by Surgery in Patients with Locally Advanced Adenocarcinom...
- Survival modeling for the estimation of transition probabilities in model-based economic evaluations in the absence of individual patient data: a tutorial.
- On being a doll.
- Molecular Profiling for Breast Cancer: A Comprehensive Review.
- Understanding the biology of ex vivo-expanded CD8 T Cells for adoptive Cell therapy: role of CD62L.
- A meta-analysis of anastrozole in combination with fulvestrant in the first line treatment of hormone receptor positive advanced breast Cancer.
- Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid Tumors.
- Influence of Treatment Modality in Outcomes for Different Stages of Resectable Esophageal AdenoCarcinomas.
- Treating breast Cancer in the 21st century: emerging biological therapies.
- Long-Term Complete Remission with nab-Paclitaxel, Bevacizumab, and Gemcitabine Combination Therapy in a Patient with Triple-Negative Metastatic Breast Cancer.
- Pneumonitis and pulmonary fibrosis in a patient receiving adjuvant docetaxel and cyclophosphamide for stage 3 breast Cancer: a case report and literature review.
- A cost effectiveness study of eribulin versus standard single-agent cytotoxic chemotherapy for women with previously treated metastatic breast Cancer.
- Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic Cancer: A phase 1 trial.
- Phase Ib Study of Drozitumab Combined With First-Line mFOLFOX6 Plus Bevacizumab in Patients With Metastatic Colorectal Cancer.
- The economic burden of metastatic breast Cancer: a U.S. managed care perspective.
- Patient with synchronous low grade leiomyosarcoma of the thigh, primary pancreatic neuroendocrine tumor, and Lung metastases: Why biopsy of metastases should be the st...
- Successful treatment of anal gland adenoCarcinoma with combined modality therapy.
- The glutathione disulfide mimetic NOV-002 inhibits cyclophosphamide-induced hematopoietic and Immune suppression by reducing oxidative stress.
- A cost-benefit analysis of bevacizumab in combination with paclitaxel in the first-line treatment of patients with metastatic breast Cancer.
- Preoperative docetaxel/cisplatin/5-fluorouracil chemotherapy in patients with locally advanced gastro-esophageal adenoCarcinoma.
- Bevacizumab in the Treatment of Metastatic Breast Cancer: Friend or Foe?
- Synergy of brief activation of CD8 T-Cells in the presence of IL-12 and adoptive transfer into lymphopenic hosts promotes tumor clearance and anti-tumor memory.
- A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor Cells.
- Eribulin mesylate, a novel microtubule inhibitor in the treatment of breast Cancer.
- Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenoCarcinoma?
- Leveraging combinatorial chemotherapy to improve outcomes in patients with pancreatic Cancer.
- A case of severe thrombotic Thrombocytopenic purpura with concomitant Legionella pneumonia: review of pathogenesis and treatment.
- Survival effects of adjuvant chemoradiotherapy after resection for pancreatic Carcinoma.
- Successful Use of Biweekly Gemcitabine Plus Nab-Paclitaxel in Two Male Patients With Stage IV Breast Cancer: Case Reports and Review of the Literature.
- Recovery from cyclophosphamide-induced lymphopenia results in expansion of immature dendritic Cells which can mediate enhanced prime-boost vaccination antitumor respon...
- Optimizing imatinib mesylate treatment in gastrointestinal stromal Tumors.
- Metastatic chest wall Malignant schwannoma responding to sorafenib: case report and literature review.
- Interferon-gamma suppresses cyclooxygenase-2 promoter activity by inhibiting C-Jun and C/EBPbeta binding.
- Adjuvant and preoperative therapy for localized gastric Cancer.
- Fatal rhabdomyolysis as a complication of ET-743 (Yondelis) chemotherapy for sarcoma.
- Epigenetic inactivation of EGFR by CpG island hypermethylation in Cancer.
- Acute respiratory distress syndrome after rituximab infusion.
- The natural history of breast Carcinoma in patients with > or = 10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy: a multiinstituti...
- Vulvar Langerhans Cell histiocytosis: a case report and review of the literature.
- Quantitative analysis of binding of transcription factor complex to biotinylated DNA probe by a streptavidin-agarose pulldown assay.
- Priming of naive CD8+ T Cells in the presence of IL-12 selectively enhances the survival of CD8+CD62Lhi Cells and results in superior anti-tumor activity in a toleroge...
- Bortezomib in combination with celecoxib in patients with advanced solid Tumors: a phase I trial.
- Phase I dose escalation study of vinorelbine and topotecan combination chemotherapy in patients with recurrent lung Cancer.
- Gemcitabine and taxanes in metastatic breast Cancer: a systematic review.
- Increased circulating myeloid-derived suppressor Cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.
- Upper gastrointestinal Tumors: current status and future perspectives.
- Nab-paclitaxel in the treatment of metastatic breast Cancer: a comprehensive review.
- Phase II study of low-dose interleukin-11 in patients with Myelodysplastic syndrome.
- Racial differences in the incidence of breast Cancer subtypes defined by combined histologic grade and hormone receptor status.
- Cellular redox pathways as a therapeutic target in the treatment of cancer.
- Phase I trial of dose-dense docetaxel and doxorubicin with or without sargramostim in patients with metastatic breast Cancer.
- Tumor suppressor gene methylation in follicular Lymphoma: a comprehensive review.
- Docetaxel for treatment of solid tumours: a systematic review of clinical data.
- Langerhans Cell histiocytosis of the female genital tract: a literature review.
- Cytokines and angiogenic factors in patients with metastatic renal Cell carcinoma treated with interferon-alpha: association of pretreatment serum levels with survival.
- Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical...
- The department without walls. Acceptability, cost, and utilization of interactive video technology.
Schools
University Of Texas Medical Branch At Galveston
University Of Texas Houston Health Science Center
University of Texas MD Anderson Cancer Center
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Basal Cell Carcinoma
- Bladder Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Six Sigma Green Belt
- CMS Meaningful Use Stage 1 Certification
- Six Sigma Champion
- Papanicolaou Corps for Cancer Research Pap Corps Fellow
- Methods in Cancer Research Workshop Travel Award
- Travel Award
- Division of Pathology Tropical Medicine Research Award
- McLaughlin Medical Student Fellow
- Dean's List
Education
-
University of Miami School of Business -
University of Texas Health Science Center -
University of Texas Medical Branch
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1962510826 | |
| NPPES Provider LastName | MONTERO | |
| NPPES Provider FirstName | ALBERTO | |
| NPPES Provider ZIPCode | 331361002 | |
| NPPES Provider State | FL | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 270.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1962510826 |
| Last Name Of The Provider | MONTERO |
| First Name Of The Provider | ALBERTO |
| View All |
Similar Doctors
|
Dr. Lindsey M. Goodman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sudipto Mukherjee, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Paolo F. Caimi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bassam N. Estfan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel Y. Heng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deepa Jagadeesh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nathan A. Pennell, MD
This Doctor is OpenDoctor Recommended.
|